table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Biopharmaceutical and Vaccines Market Size Analysis from 2022 to 2027
1.5.1 Global Biopharmaceutical and Vaccines Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Biopharmaceutical and Vaccines Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Biopharmaceutical and Vaccines Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Biopharmaceutical and Vaccines Industry Impact
Chapter 2 Global Biopharmaceutical and Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biopharmaceutical and Vaccines (Volume and Value) by Type
2.1.1 Global Biopharmaceutical and Vaccines Consumption and Market Share by Type (2016-2021)
2.1.2 Global Biopharmaceutical and Vaccines Revenue and Market Share by Type (2016-2021)
2.2 Global Biopharmaceutical and Vaccines (Volume and Value) by Application
2.2.1 Global Biopharmaceutical and Vaccines Consumption and Market Share by Application (2016-2021)
2.2.2 Global Biopharmaceutical and Vaccines Revenue and Market Share by Application (2016-2021)
2.3 Global Biopharmaceutical and Vaccines (Volume and Value) by Regions
2.3.1 Global Biopharmaceutical and Vaccines Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Biopharmaceutical and Vaccines Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biopharmaceutical and Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Biopharmaceutical and Vaccines Consumption by Regions (2016-2021)
4.2 North America Biopharmaceutical and Vaccines Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Biopharmaceutical and Vaccines Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Biopharmaceutical and Vaccines Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Biopharmaceutical and Vaccines Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Biopharmaceutical and Vaccines Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Biopharmaceutical and Vaccines Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Biopharmaceutical and Vaccines Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Biopharmaceutical and Vaccines Sales, Consumption, Export, Import (2016-2021)
4.10 South America Biopharmaceutical and Vaccines Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Biopharmaceutical and Vaccines Market Analysis
5.1 North America Biopharmaceutical and Vaccines Consumption and Value Analysis
5.1.1 North America Biopharmaceutical and Vaccines Market Under COVID-19
5.2 North America Biopharmaceutical and Vaccines Consumption Volume by Types
5.3 North America Biopharmaceutical and Vaccines Consumption Structure by Application
5.4 North America Biopharmaceutical and Vaccines Consumption by Top Countries
5.4.1 United States Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
5.4.2 Canada Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
5.4.3 Mexico Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
Chapter 6 East Asia Biopharmaceutical and Vaccines Market Analysis
6.1 East Asia Biopharmaceutical and Vaccines Consumption and Value Analysis
6.1.1 East Asia Biopharmaceutical and Vaccines Market Under COVID-19
6.2 East Asia Biopharmaceutical and Vaccines Consumption Volume by Types
6.3 East Asia Biopharmaceutical and Vaccines Consumption Structure by Application
6.4 East Asia Biopharmaceutical and Vaccines Consumption by Top Countries
6.4.1 China Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
6.4.2 Japan Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
6.4.3 South Korea Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
Chapter 7 Europe Biopharmaceutical and Vaccines Market Analysis
7.1 Europe Biopharmaceutical and Vaccines Consumption and Value Analysis
7.1.1 Europe Biopharmaceutical and Vaccines Market Under COVID-19
7.2 Europe Biopharmaceutical and Vaccines Consumption Volume by Types
7.3 Europe Biopharmaceutical and Vaccines Consumption Structure by Application
7.4 Europe Biopharmaceutical and Vaccines Consumption by Top Countries
7.4.1 Germany Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
7.4.2 UK Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
7.4.3 France Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
7.4.4 Italy Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
7.4.5 Russia Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
7.4.6 Spain Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
7.4.7 Netherlands Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
7.4.8 Switzerland Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
7.4.9 Poland Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
Chapter 8 South Asia Biopharmaceutical and Vaccines Market Analysis
8.1 South Asia Biopharmaceutical and Vaccines Consumption and Value Analysis
8.1.1 South Asia Biopharmaceutical and Vaccines Market Under COVID-19
8.2 South Asia Biopharmaceutical and Vaccines Consumption Volume by Types
8.3 South Asia Biopharmaceutical and Vaccines Consumption Structure by Application
8.4 South Asia Biopharmaceutical and Vaccines Consumption by Top Countries
8.4.1 India Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
8.4.2 Pakistan Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Biopharmaceutical and Vaccines Market Analysis
9.1 Southeast Asia Biopharmaceutical and Vaccines Consumption and Value Analysis
9.1.1 Southeast Asia Biopharmaceutical and Vaccines Market Under COVID-19
9.2 Southeast Asia Biopharmaceutical and Vaccines Consumption Volume by Types
9.3 Southeast Asia Biopharmaceutical and Vaccines Consumption Structure by Application
9.4 Southeast Asia Biopharmaceutical and Vaccines Consumption by Top Countries
9.4.1 Indonesia Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
9.4.2 Thailand Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
9.4.3 Singapore Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
9.4.4 Malaysia Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
9.4.5 Philippines Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
9.4.6 Vietnam Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
9.4.7 Myanmar Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
Chapter 10 Middle East Biopharmaceutical and Vaccines Market Analysis
10.1 Middle East Biopharmaceutical and Vaccines Consumption and Value Analysis
10.1.1 Middle East Biopharmaceutical and Vaccines Market Under COVID-19
10.2 Middle East Biopharmaceutical and Vaccines Consumption Volume by Types
10.3 Middle East Biopharmaceutical and Vaccines Consumption Structure by Application
10.4 Middle East Biopharmaceutical and Vaccines Consumption by Top Countries
10.4.1 Turkey Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
10.4.3 Iran Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
10.4.5 Israel Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
10.4.6 Iraq Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
10.4.7 Qatar Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
10.4.8 Kuwait Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
10.4.9 Oman Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
Chapter 11 Africa Biopharmaceutical and Vaccines Market Analysis
11.1 Africa Biopharmaceutical and Vaccines Consumption and Value Analysis
11.1.1 Africa Biopharmaceutical and Vaccines Market Under COVID-19
11.2 Africa Biopharmaceutical and Vaccines Consumption Volume by Types
11.3 Africa Biopharmaceutical and Vaccines Consumption Structure by Application
11.4 Africa Biopharmaceutical and Vaccines Consumption by Top Countries
11.4.1 Nigeria Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
11.4.2 South Africa Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
11.4.3 Egypt Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
11.4.4 Algeria Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
11.4.5 Morocco Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
Chapter 12 Oceania Biopharmaceutical and Vaccines Market Analysis
12.1 Oceania Biopharmaceutical and Vaccines Consumption and Value Analysis
12.2 Oceania Biopharmaceutical and Vaccines Consumption Volume by Types
12.3 Oceania Biopharmaceutical and Vaccines Consumption Structure by Application
12.4 Oceania Biopharmaceutical and Vaccines Consumption by Top Countries
12.4.1 Australia Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
12.4.2 New Zealand Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
Chapter 13 South America Biopharmaceutical and Vaccines Market Analysis
13.1 South America Biopharmaceutical and Vaccines Consumption and Value Analysis
13.1.1 South America Biopharmaceutical and Vaccines Market Under COVID-19
13.2 South America Biopharmaceutical and Vaccines Consumption Volume by Types
13.3 South America Biopharmaceutical and Vaccines Consumption Structure by Application
13.4 South America Biopharmaceutical and Vaccines Consumption Volume by Major Countries
13.4.1 Brazil Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
13.4.2 Argentina Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
13.4.3 Columbia Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
13.4.4 Chile Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
13.4.5 Venezuela Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
13.4.6 Peru Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
13.4.8 Ecuador Biopharmaceutical and Vaccines Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Biopharmaceutical and Vaccines Business
14.1 Novartis
14.1.1 Novartis Company Profile
14.1.2 Novartis Biopharmaceutical and Vaccines Product Specification
14.1.3 Novartis Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Pfizer
14.2.1 Pfizer Company Profile
14.2.2 Pfizer Biopharmaceutical and Vaccines Product Specification
14.2.3 Pfizer Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Sanofi
14.3.1 Sanofi Company Profile
14.3.2 Sanofi Biopharmaceutical and Vaccines Product Specification
14.3.3 Sanofi Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Roche
14.4.1 Roche Company Profile
14.4.2 Roche Biopharmaceutical and Vaccines Product Specification
14.4.3 Roche Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Abbott
14.5.1 Abbott Company Profile
14.5.2 Abbott Biopharmaceutical and Vaccines Product Specification
14.5.3 Abbott Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Biogen Idec
14.6.1 Biogen Idec Company Profile
14.6.2 Biogen Idec Biopharmaceutical and Vaccines Product Specification
14.6.3 Biogen Idec Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Regeneron Pharmaceuticals
14.7.1 Regeneron Pharmaceuticals Company Profile
14.7.2 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product Specification
14.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Alexion Pharmaceuticals
14.8.1 Alexion Pharmaceuticals Company Profile
14.8.2 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product Specification
14.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Johnson and Johnson
14.9.1 Johnson and Johnson Company Profile
14.9.2 Johnson and Johnson Biopharmaceutical and Vaccines Product Specification
14.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 GlaxoSmithKline
14.10.1 GlaxoSmithKline Company Profile
14.10.2 GlaxoSmithKline Biopharmaceutical and Vaccines Product Specification
14.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Merck
14.11.1 Merck Company Profile
14.11.2 Merck Biopharmaceutical and Vaccines Product Specification
14.11.3 Merck Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Lonza
14.12.1 Lonza Company Profile
14.12.2 Lonza Biopharmaceutical and Vaccines Product Specification
14.12.3 Lonza Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Boehringer Ingelheim
14.13.1 Boehringer Ingelheim Company Profile
14.13.2 Boehringer Ingelheim Biopharmaceutical and Vaccines Product Specification
14.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Rentschler
14.14.1 Rentschler Company Profile
14.14.2 Rentschler Biopharmaceutical and Vaccines Product Specification
14.14.3 Rentschler Biopharmaceutical and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Biopharmaceutical and Vaccines Market Forecast (2022-2027)
15.1 Global Biopharmaceutical and Vaccines Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Biopharmaceutical and Vaccines Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Biopharmaceutical and Vaccines Value and Growth Rate Forecast (2022-2027)
15.2 Global Biopharmaceutical and Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Biopharmaceutical and Vaccines Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Biopharmaceutical and Vaccines Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Biopharmaceutical and Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Biopharmaceutical and Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Biopharmaceutical and Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Biopharmaceutical and Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Biopharmaceutical and Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Biopharmaceutical and Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Biopharmaceutical and Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Biopharmaceutical and Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Biopharmaceutical and Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Biopharmaceutical and Vaccines Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Biopharmaceutical and Vaccines Consumption Forecast by Type (2022-2027)
15.3.2 Global Biopharmaceutical and Vaccines Revenue Forecast by Type (2022-2027)
15.3.3 Global Biopharmaceutical and Vaccines Price Forecast by Type (2022-2027)
15.4 Global Biopharmaceutical and Vaccines Consumption Volume Forecast by Application (2022-2027)
15.5 Biopharmaceutical and Vaccines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
